Antonio Lembo
Antonio Lembo has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
Gian Luca Sardone
GSK Vaccines, Analytical R&D , Via Fiorentina, 1, 53100, Siena
2 shared publicationsMichela Aurilia
GSK Vaccines, Analytical R&D , Via Fiorentina, 1, 53100, Siena
2 shared publicationsAntonio Molinaro
Department of Chemical Sciences, University of Naples Federico II, Naples, Italy
1 shared publication- Cristina De Castro
Department of Chemical Sciences, University of Naples Federico II, Naples, Italy
1 shared publication - Cristina De Castro
Department of Chemical Sciences, University of Napoli Federico II Complesso Universitario Monte Santangelo, Via Cintia 4, I-80126, Naples, Italy
1 shared publication Francesco Berti
GSK Vaccines, Analytical R&D, Siena, Italy
1 shared publication
Latest Publications
- Open Access
- 5 August 2026
- Published by Oxford University Press (OUP) in Glycobiology
- Vol. 36 (10)
Site-specific and global glycan analysis of the human cytomegalovirus pentameric glycoprotein by high resolution mass spectrometry
The Human Cytomegalovirus (HCMV) gH/gL/UL128/UL130/UL131A complex (Pentamer) is among the candidates for the development of a vaccine against HCMV; indeed, it brought to more immunogenic formulations which were able to protect the fetus against vertical transmission in pregnant women. Pentamer-specific antibodies have shown to be hundredfold more potent than gB or gH/gL antibodies, endowed with strong neutralizing activity. The often inadequate antibody immune response elicited by glycoprotein antigen has been, in part, attributed to the abundance of glycosylation on the protein. Here, we determine the composite glycan population of each of the N-linked and O-linked glycosylation sites present on the Pentamer by multienzymatic proteolysis and mass spectrometry; furthermore, total N-glycans profiles of Pentamer expressed in different cell systems have been compared exploiting the glycan fluorescent labeling and the immunogenicity of Pentamer with different glycosylation patterns has been investigated. Our analysis reveals the presence of underprocessed oligomannose-type glycans on some glycosylation sequons, which are probably derived as a result of sterically reduced accessibility to glycan processing enzymes. Furthermore, the antigen glycosylation pattern affects the elicitation of neutralizing antibodies in mice.
- 5 August 2026
- Published by Oxford University Press (OUP) in Glycobiology
- Vol. 36 (10)
Open AccessSite-specific and global glycan analysis of the human cytomegalovirus pentameric glycoprotein by high resolution mass spectrometry
The Human Cytomegalovirus (HCMV) gH/gL/UL128/UL130/UL131A complex (Pentamer) is among the candidates for the development of a vaccine against HCMV; indeed, it brought to more immunogenic formulations which were able to protect the fetus against vertical transmission in pregnant women. Pentamer-specific antibodies have shown to be hundredfold more potent than gB or gH/gL antibodies, endowed with strong neutralizing activity. The often inadequate antibody immune response elicited by glycoprotein antigen has been, in part, attributed to the abundance of glycosylation on the protein. Here, we determine the composite glycan population of each of the N-linked and O-linked glycosylation sites present on the Pentamer by multienzymatic proteolysis and mass spectrometry; furthermore, total N-glycans profiles of Pentamer expressed in different cell systems have been compared exploiting the glycan fluorescent labeling and the immunogenicity of Pentamer with different glycosylation patterns has been investigated. Our analysis reveals the presence of underprocessed oligomannose-type glycans on some glycosylation sequons, which are probably derived as a result of sterically reduced accessibility to glycan processing enzymes. Furthermore, the antigen glycosylation pattern affects the elicitation of neutralizing antibodies in mice.
- Open Access
- 26 January 2026
- Published by Elsevier in Carbohydrate Research
- Vol. 562, 109838
Dissecting the glycoprofile of the human cytomegalovirus protein gB by comprehensive mass spectrometry analysis
- 26 January 2026
- Published by Elsevier in Carbohydrate Research
- Vol. 562, 109838
Open AccessDissecting the glycoprofile of the human cytomegalovirus protein gB by comprehensive mass spectrometry analysis